Literature DB >> 26883890

Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache.

Wm Jeptha Davenport1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26883890      PMCID： PMC4754189          DOI： 10.1503/cmaj.1150082

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.

Authors:  Matthias Karst; John H Halpern; Michael Bernateck; Torsten Passie
Journal:  Cephalalgia       Date:  2010-03-26       Impact factor: 6.292

Review 2.  Psychedelic medicine: a re-emerging therapeutic paradigm.

Authors:  Kenneth W Tupper; Evan Wood; Richard Yensen; Matthew W Johnson
Journal:  CMAJ       Date:  2015-09-08       Impact factor: 8.262

3.  Response of cluster headache to psilocybin and LSD.

Authors:  R Andrew Sewell; John H Halpern; Harrison G Pope
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

Review 4.  Licit and illicit drug use in cluster headache.

Authors:  Amelie Govare; Elizabeth Leroux
Journal:  Curr Pain Headache Rep       Date:  2014-05
  4 in total
  4 in total

1.  Ceremonial "plant medicine" use and its relationship to recreational drug use: an exploratory study.

Authors:  Caroline Dorsen; Joseph Palamar; Michele G Shedlin
Journal:  Addict Res Theory       Date:  2018-03-30

2.  Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.

Authors:  Patrick C Dolder; Yasmin Schmid; Andrea E Steuer; Thomas Kraemer; Katharina M Rentsch; Felix Hammann; Matthias E Liechti
Journal:  Clin Pharmacokinet       Date:  2017-10       Impact factor: 6.447

3.  Alterations of consciousness and mystical-type experiences after acute LSD in humans.

Authors:  Matthias E Liechti; Patrick C Dolder; Yasmin Schmid
Journal:  Psychopharmacology (Berl)       Date:  2016-10-07       Impact factor: 4.530

Review 4.  Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Justin Grant; Amza Ali; Lorenzo Gordon; Wilfred Ngwa
Journal:  Molecules       Date:  2022-04-14       Impact factor: 4.927
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.